Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to a study … [Read more...]
EMERGING TESTS
Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy
February 18, 2019
PRECISION MEDICINE
Newborn Sequencing Delivers Some Unanticipated Findings
January 22, 2019
Newborn genomic sequencing (NGS) can identify risk for a wide range of disorders that otherwise may not be detected, even in seemingly healthy babies, according to a study published Jan. 3 in the … [Read more...]
TESTING TRENDS
Zika Blood Screening Not Cost-Effective, Study Finds
January 22, 2019
Screening blood donors for Zika virus is not cost-effective in the United States or Puerto Rico, according to a study published Jan. 8 in the Annals of Internal Medicine. Despite U.S. Food and Drug … [Read more...]
TESTING TRENDS
Low-Value, Blood Glucose Self-Monitoring is Common
January 21, 2019
A substantial percentage of patients with type 2 diabetes may be inappropriately self-monitoring blood glucose, according to a research letter published Dec. 10 in JAMA Internal Medicine. Despite … [Read more...]
GUIDELINES
Pre-Op Urine Screening Not Necessary
December 31, 2018
Routine preoperative urine screening offers no clinical benefit, according to a large study published Dec. 12 in JAMA Surgery. Treating asymptomatic bacteriuria detected by screening does not cut the … [Read more...]
GUIDELINES
Ideal Age of Last Cervical Cancer Screening Depends on Test Type
November 26, 2018
With the adoption of cotesting—human papillomavirus (HPV) plus Pap cytology—cervical cancer screening methodology has focused primarily on the preferred frequency of combined testing. However, a new … [Read more...]
TESTING STRATEGY
Penicillin Allergy Testing Underused, Could Lead to Cost Savings
November 26, 2018
Once a patient is labeled as having a penicillin allergy, it is rarely revisited. The label sticks and increases the patient's risk of receiving subsequent suboptimal, alternative antibiotic therapy, … [Read more...]
TESTING STRATEGY
Evidence Suggests Need for Expanded HCV Testing, Particularly Coupled With Opioid Screening in Young People
November 5, 2018
Current hepatitis C virus (HCV) screening strategies may not be adequate in the face of the opioid epidemic. Previous screening guidelines have focused on reaching the estimated 2.7 million persons … [Read more...]
PRECISION MEDICINE
Majority of Patients Unaware of their BRCA Status
October 29, 2018
Eight in 10 patients carrying a BRCA mutation are unaware of their status, according to a study published Sept. 21 in JAMA Network Open. The authors say these findings highlight that previous BRCA … [Read more...]
GUIDELINES
Rapid Molecular Testing Saves Hospitals Time, Money Ruling Out TB
October 1, 2018
Molecular testing facilitates faster discontinuation of respiratory isolation for individuals undergoing evaluation for active tuberculosis (TB) in U.S. hospitals, according to a study published Aug. … [Read more...]
